Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 113 articles:
HTML format



Single Articles


    September 2021
  1. CHANG L, Lacy BE, Moshiree B, Kassebaum A, et al
    Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
    Am J Gastroenterol. 2021;116:1929-1937.
    PubMed     Abstract available


    July 2021
  2. NEE J, Ballou S, Kelley JM, Kaptchuk TJ, et al
    Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 Jul 28. pii: 00000434-990000000-00060.
    PubMed     Abstract available


  3. KESZTHELYI D
    Irritable Bowel Syndrome and Functional Dyspepsia: Different Ends of the Same Spectrum of Intestinal Barrier Dysfunction?
    Am J Gastroenterol. 2021;116:1556.
    PubMed    


    May 2021
  4. SHAH ED, Lacy BE, Chey WD, Chang L, et al
    Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98765.
    PubMed     Abstract available


  5. YU V, Ballou S, Hassan R, Singh P, et al
    Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders.
    Am J Gastroenterol. 2021 May 18. pii: 00000434-900000000-98775.
    PubMed     Abstract available


  6. BRENNER DM, Lacy BE
    Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98778.
    PubMed     Abstract available


  7. SCHMULSON M
    Probiotics: To Use or Not to Use? That Is the Question.
    Am J Gastroenterol. 2021 May 10. pii: 00000434-900000000-98783.
    PubMed     Abstract available


    April 2021
  8. GOODOORY VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, et al
    Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021 Apr 6. pii: 00000434-900000000-98826.
    PubMed     Abstract available


  9. MIDENFJORD I, Borg A, Tornblom H, Simren M, et al
    Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021;116:769-779.
    PubMed     Abstract available


  10. SHAH ED, Chang L, Salwen-Deremer JK, Gibson PR, et al
    Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Am J Gastroenterol. 2021;116:748-757.
    PubMed     Abstract available


    March 2021
  11. BUSHYHEAD DW
    Continuing Medical Education Questions: March 2021: Irritable Bowel Syndrome in.
    Am J Gastroenterol. 2021;116:456.
    PubMed     Abstract available


    February 2021
  12. PLASSE TF
    Reply to Black and Ford.
    Am J Gastroenterol. 2021;116:429.
    PubMed    


    January 2021
  13. MOOSAVI S, Pimentel M, Wong MS, Rezaie A, et al
    Irritable Bowel Syndrome in Pregnancy.
    Am J Gastroenterol. 2021 Jan 21. pii: 00000434-900000000-98935.
    PubMed     Abstract available


  14. STALLER KD
    Continuing Medical Education Questions: January 2021.
    Am J Gastroenterol. 2021;116:16.
    PubMed     Abstract available


  15. STALLER KD
    Continuing Medical Education Questions: January 2021.
    Am J Gastroenterol. 2021;116:16.
    PubMed     Abstract available


    December 2020
  16. LACY BE, Pimentel M, Brenner DM, Chey WD, et al
    ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Dec 14. doi: 10.14309/ajg.0000000000001036.
    PubMed     Abstract available


  17. CHEY WD, Lembo AJ, Yang Y, Rosenbaum DP, et al
    Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    November 2020
  18. BLACK CJ, Ford AC
    Efficacy of Ondansetron for Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000000932.
    PubMed    


  19. MIDENFJORD I, Borg A, Tornblom H, Simren M, et al
    Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Nov 4. doi: 10.14309/ajg.0000000000001038.
    PubMed     Abstract available


  20. STALLER K, Cash BD
    Myths and Misconceptions About Constipation: A New View for the 2020s.
    Am J Gastroenterol. 2020;115:1741-1745.
    PubMed    


    October 2020
  21. BLACK CJ, Yiannakou Y, Guthrie EA, West R, et al
    A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000975.
    PubMed     Abstract available


  22. MELCHIOR C, Simren M
    Positive Effect of Bimodal Release Ondansetron in Irritable Bowel Syndrome With Diarrhea: Relevance of Low-Grade Inflammation?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001022.
    PubMed     Abstract available


  23. CHEY WD, Sayuk GS, Bartolini W, Reasner DS, et al
    Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000967.
    PubMed     Abstract available


  24. SHAH ED, Chang L, Salwen-Deremer JK, Gibson PR, et al
    Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000989.
    PubMed     Abstract available


    September 2020
  25. BARBERIO B, Houghton LA, Yiannakou Y, Savarino EV, et al
    Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000946.
    PubMed     Abstract available


  26. MANSUETO P, Soresi M, Candore G, Garlisi C, et al
    Autoimmunity Features in Patients With Non-Celiac Wheat Sensitivity.
    Am J Gastroenterol. 2020 Sep 25. doi: 10.14309/ajg.0000000000000919.
    PubMed     Abstract available


    August 2020
  27. RUFFLE JK, Tinkler L, Emmett C, Ford AC, et al
    Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000816.
    PubMed     Abstract available


    July 2020
  28. GUILARTE M, Vicario M, Martinez C, de Torres I, et al
    Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Jul 27. doi: 10.14309/ajg.0000000000000789.
    PubMed     Abstract available


    June 2020
  29. PLASSE TF, Barton G, Davidson E, Abramson D, et al
    Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial.
    Am J Gastroenterol. 2020 Jun 24. doi: 10.14309/ajg.0000000000000727.
    PubMed     Abstract available


  30. CAMILLERI M, Vijayvargiya P
    The Role of Bile Acids in Chronic Diarrhea.
    Am J Gastroenterol. 2020 Jun 11. doi: 10.14309/ajg.0000000000000696.
    PubMed     Abstract available


  31. REZAIE A
    Shedding Light on Elevated Baseline Hydrogen and Flat-Line Patterns During Breath Testing.
    Am J Gastroenterol. 2020;115:956-957.
    PubMed    


    May 2020
  32. WILSON B, Rossi M, Kanno T, Parkes GC, et al
    beta-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
    Am J Gastroenterol. 2020 May 20. doi: 10.14309/ajg.0000000000000641.
    PubMed     Abstract available


    April 2020
  33. OH SJ, Fuller G, Patel D, Khalil C, et al
    Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy.
    Am J Gastroenterol. 2020 Apr 23. doi: 10.14309/ajg.0000000000000614.
    PubMed     Abstract available


    March 2020
  34. BLACK CJ, Ford AC
    Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives.
    Am J Gastroenterol. 2020 Mar 2. doi: 10.14309/ajg.0000000000000569.
    PubMed    


  35. BRENNER DM, Sayuk GS, Gutman CR, Jo E, et al
    Response to Black et al.
    Am J Gastroenterol. 2020;115:484-485.
    PubMed    


    February 2020
  36. STALLER K, Olen O, Soderling J, Roelstraete B, et al
    Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study.
    Am J Gastroenterol. 2020 Feb 28. doi: 10.14309/ajg.0000000000000573.
    PubMed     Abstract available


  37. DEUTSCH JK, Levitt J, Hass DJ
    Complementary and Alternative Medicine for Functional Gastrointestinal Disorders.
    Am J Gastroenterol. 2020 Feb 20. doi: 10.14309/ajg.0000000000000539.
    PubMed     Abstract available


  38. SHAH ED, Suresh S, Jou J, Chey WD, et al
    Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.
    Am J Gastroenterol. 2020 Feb 4. doi: 10.14309/ajg.0000000000000530.
    PubMed     Abstract available


    January 2020
  39. CHEY WD, Lembo AJ, Rosenbaum DP
    Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1).
    Am J Gastroenterol. 2020 Jan 13. doi: 10.14309/ajg.0000000000000516.
    PubMed     Abstract available


  40. BUTT I, Kasmin F, Ekekezie C, Perler BK, et al
    Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant.
    Am J Gastroenterol. 2020 Jan 10. doi: 10.14309/ajg.0000000000000499.
    PubMed     Abstract available


  41. BLACK CJ, Houghton LA, Ford AC
    Efficacy of Eluxadoline in Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2020 Jan 10. doi: 10.14309/ajg.0000000000000518.
    PubMed    


  42. SHAH A, Talley NJ, Jones M, Kendall BJ, et al
    Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000504.
    PubMed     Abstract available


  43. SHAH ED, Almario CV, Spiegel BM, Chey WD, et al
    Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000502.
    PubMed     Abstract available


  44. TALLEY NJ
    What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model.
    Am J Gastroenterol. 2020;115:41-48.
    PubMed     Abstract available


    November 2019
  45. REZAIE A, Heimanson Z, McCallum R, Pimentel M, et al
    Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
    Am J Gastroenterol. 2019 Nov 1. doi: 10.14309/ajg.0000000000000444.
    PubMed     Abstract available


    October 2019
  46. SCALLAN WALTER EJ, Crim SM, Bruce BB, Griffin PM, et al
    Postinfectious Irritable Bowel Syndrome After Campylobacter Infection.
    Am J Gastroenterol. 2019;114:1649-1656.
    PubMed     Abstract available


    September 2019
  47. DYDYK AM, Gupta N, Rej A, Trott N, et al
    A Gluten-Free Diet: The Express Route to Fructan Reduction.
    Am J Gastroenterol. 2019;114:1553.
    PubMed     Abstract available


    July 2019
  48. BRENNER DM, Sayuk GS, Gutman CR, Jo E, et al
    Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study.
    Am J Gastroenterol. 2019 Jul 26. doi: 10.14309/ajg.0000000000000327.
    PubMed     Abstract available


  49. CASH BD, Lacy BE, Schoenfeld PS, Dove LS, et al
    Response to Lai.
    Am J Gastroenterol. 2019;114:1177-1178.
    PubMed     Abstract available


  50. LAI SW
    Safety of Eluxadoline Use.
    Am J Gastroenterol. 2019;114:1176-1177.
    PubMed    


    June 2019
  51. UNO Y
    Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome.
    Am J Gastroenterol. 2019 Jun 14. doi: 10.14309/ajg.0000000000000298.
    PubMed    


    May 2019
  52. SHAUKAT A, Brenner DM
    Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?
    Am J Gastroenterol. 2019 May 1. doi: 10.14309/ajg.0000000000000259.
    PubMed     Abstract available


    March 2019
  53. XU D, Chen VL, Steiner CA, Berinstein JA, et al
    Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2019 Mar 20. doi: 10.14309/ajg.0000000000000198.
    PubMed     Abstract available


  54. B BIOMED GB, Carroll G, Mathe A, Horvat J, et al
    Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
    Am J Gastroenterol. 2019;114:429-436.
    PubMed     Abstract available


    February 2019
  55. LUSTBADER I
    Continuing Medical Education Questions: February 2019.
    Am J Gastroenterol. 2019;114:200.
    PubMed     Abstract available


  56. SCARLATA K
    Low FODMAP Diet: What Your Patients Need to Know.
    Am J Gastroenterol. 2019;114:189-191.
    PubMed    


    January 2019
  57. SCHMULSON M
    Is Post Infection-Irritable Bowel Syndrome Less Frequent in Mexico?
    Am J Gastroenterol. 2019 Jan 21. doi: 10.14309/ajg.0000000000000098.
    PubMed    


  58. CHEY WD
    Elimination Diets for Irritable Bowel Syndrome: Approaching the End of the Beginning.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000099.
    PubMed     Abstract available


  59. SCHOENFELD P, Shah ED
    Response to Sierra and Gomez.
    Am J Gastroenterol. 2019;114:169-170.
    PubMed     Abstract available


  60. SIERRA F, Gomez DG
    Efficacy and Tolerability of Guanylate Cyclase-C Agonist: Encouraging Results With Insignificant Clinical Importance.
    Am J Gastroenterol. 2019;114:169.
    PubMed    


    November 2018
  61. BURNS G, Carroll G, Mathe A, Horvat J, et al
    Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0377.
    PubMed     Abstract available


  62. LACKNER JM, Jaccard J, Radziwon CD, Firth RS, et al
    Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0396.
    PubMed     Abstract available


    October 2018
  63. KAMAL A, Pimentel M
    Influence of Dietary Restriction on Irritable Bowel Syndrome.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0241.
    PubMed     Abstract available


    September 2018
  64. FRANDEMARK A, Tornblom H, Jakobsson S, Simren M, et al
    Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.
    Am J Gastroenterol. 2018 Sep 25. pii: 10.1038/s41395-018-0262.
    PubMed     Abstract available


  65. FORD AC, Lacy BE, Harris LA, Quigley EM, et al
    Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0222.
    PubMed     Abstract available


    August 2018
  66. RAHMAN MM, Ghoshal UC, Sultana S, Kibria MG, et al
    Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a Tropical Country: A Prospective Cohort Study.
    Am J Gastroenterol. 2018 Aug 31. pii: 10.1038/s41395-018-0208.
    PubMed     Abstract available


    July 2018
  67. DIONNE J, Ford AC, Yuan Y, Chey WD, et al
    A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2018 Jul 26. pii: 10.1038/s41395-018-0195.
    PubMed     Abstract available


    June 2018
  68. FORD AC, Moayyedi P, Chey WD, Harris LA, et al
    American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0084.
    PubMed    


  69. POTTER MDE, Walker MM, Jones MP, Koloski NA, et al
    Wheat Intolerance and Chronic Gastrointestinal Symptoms in an Australian Population-based Study: Association Between Wheat Sensitivity, Celiac Disease and Functional Gastrointestinal Disorders.
    Am J Gastroenterol. 2018 Jun 19. pii: 10.1038/s41395-018-0095.
    PubMed     Abstract available


  70. SCHNABEL L, Buscail C, Sabate JM, Bouchoucha M, et al
    Association Between Ultra-Processed Food Consumption and Functional Gastrointestinal Disorders: Results From the French NutriNet-Sante Cohort.
    Am J Gastroenterol. 2018 Jun 15. pii: 10.1038/s41395-018-0137.
    PubMed     Abstract available


  71. AZIZ I, Tornblom H, Palsson OS, Whitehead WE, et al
    How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0074.
    PubMed     Abstract available


  72. MOHAPATRA S, Singh DP, Alcid D, Pitchumoni CS, et al
    Beyond O&P Times Three.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0083.
    PubMed     Abstract available


    May 2018
  73. SCHILLER LR
    Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0032.
    PubMed     Abstract available


    March 2018
  74. BRENNER DM, Fogel R, Dorn SD, Krause R, et al
    Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
    Am J Gastroenterol. 2018 Mar 15. pii: 10.1038/s41395-018-0026.
    PubMed     Abstract available


  75. HAMMER J
    Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test.
    Am J Gastroenterol. 2018 Mar 13. pii: ajg201816. doi: 10.1038/ajg.2018.
    PubMed     Abstract available


    February 2018
  76. GRACIE DJ, Hamlin PJ, Ford AC
    Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0021.
    PubMed     Abstract available


    January 2018
  77. SHAH ED, Kim HM, Schoenfeld P
    Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg2017495. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    December 2017
  78. LACY BE, Ford AC, Talley NJ
    Quality of Care and the Irritable Bowel Syndrome: Is Now the Time to Set Standards?
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017442. doi: 10.1038/ajg.2017.
    PubMed    


    November 2017
  79. MEARIN F
    Irritable Bowel Syndrome: Pain in Spain.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed    


    October 2017
  80. CROTEAU R, Barkin JS
    Safety of Eluxadoline in Patients With Irritable Bowel Syndrome.
    Am J Gastroenterol. 2017;112:1616.
    PubMed    


  81. CASH BD, Lacy BE, Schoenfeld PS, Dove LS, et al
    Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder.
    Am J Gastroenterol. 2017;112:1619-1620.
    PubMed    


    August 2017
  82. TUCK CJ, Taylor KM, Gibson PR, Barrett JS, et al
    Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by alpha-Galactosidase Treatment.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    July 2017
  83. UNO Y
    Enigma of Intestinal Gas in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2017;112:1166-1167.
    PubMed    


    June 2017
  84. KESZTHELYI D, Ringel Y
    Editorial: Clinical Implications of Diagnosing Irritable Bowel Syndrome: Do All Roads Need to Lead to Rome?
    Am J Gastroenterol. 2017;112:900-902.
    PubMed     Abstract available


    May 2017
  85. MALAGELADA JR, Accarino A, Azpiroz F
    Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.
    Am J Gastroenterol. 2017 May 16. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    April 2017
  86. LACY BE, Chey WD, Cash BD, Lembo AJ, et al
    Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    March 2017
  87. PETERS SA, Edogawa S, Sundt WJ, Dyer RB, et al
    Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function.
    Am J Gastroenterol. 2017 Mar 21. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    February 2017
  88. CHEY WD, Lembo AJ, Rosenbaum DP
    Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.
    Am J Gastroenterol. 2017 Feb 28. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    January 2017
  89. SAYUK GS, Wolf R, Chang L
    Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.
    Am J Gastroenterol. 2017 Jan 17. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  90. CHANG BW, Rezaie A
    Irritable Bowel Syndrome-Like Symptoms Following Fecal Microbiota Transplantation: A Possible Donor-Dependent Complication.
    Am J Gastroenterol. 2017;112:186-187.
    PubMed    


    December 2016
  91. LAM C, Chaddock G, Marciani Laurea L, Costigan C, et al
    Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  92. CASH BD, Lacy BE, Schoenfeld PS, Dove LS, et al
    Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.
    Am J Gastroenterol. 2016 Dec 6. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    November 2016
  93. BONNERT M, Olen O, Lalouni M, Benninga MA, et al
    Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Am J Gastroenterol. 2016 Nov 15. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  94. RINGEL-KULKA T, McRorie J, Ringel Y
    Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
    Am J Gastroenterol. 2016 Nov 15. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    October 2016
  95. IRVINE AJ, Chey WD, Ford AC
    Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2016 Oct 18. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  96. ESWARAN SL, Chey WD, Han-Markey T, Ball S, et al
    A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  97. PASALAR M, Mosaffa-Jahromi M, Lankarani KB
    Toward Food Therapy for Irritable Bowel Syndrome.
    Am J Gastroenterol. 2016;111:1499-1500.
    PubMed    


    September 2016
  98. DE BORTOLI N, Frazzoni L, Savarino EV, Frazzoni M, et al
    Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.
    Am J Gastroenterol. 2016 Sep 20. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    August 2016
  99. TALLEY NJ
    Board Review Vignette: Irritable Bowel Syndrome.
    Am J Gastroenterol. 2016 Aug 16. doi: 10.1038/ajg.2016.
    PubMed    


  100. SOOD R, Camilleri M, Gracie DJ, Gold MJ, et al
    Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.
    Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    July 2016
  101. LOWE B, Lohse A, Andresen V, Vettorazzi E, et al
    The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study.
    Am J Gastroenterol. 2016 Jul 5. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    June 2016
  102. BENNET SM, Polster A, Tornblom H, Isaksson S, et al
    Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
    Am J Gastroenterol. 2016 Jun 7. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    March 2016
  103. GUPTA A, Chey WD
    Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?
    Am J Gastroenterol. 2016;111:305-6.
    PubMed    


    February 2016
  104. PIMENTEL M
    Breath Testing for Small Intestinal Bacterial Overgrowth: Should We Bother?
    Am J Gastroenterol. 2016 Feb 23. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  105. CHEY WD
    Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome.
    Am J Gastroenterol. 2016 Feb 9. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


    January 2016
  106. RIDDLE MS, Welsh M, Porter CK, Nieh C, et al
    The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study.
    Am J Gastroenterol. 2016 Jan 5. doi: 10.1038/ajg.2015.
    PubMed     Abstract available


  107. FARMER AD, Hobson AR
    Intraluminal pH As a Pathophysiological Biomarker of Fermentation in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2016;111:145.
    PubMed    


  108. CHOI CH, Ringel-Kulka T, Ringel Y
    Response to Valeur et al. and Farmer et al.
    Am J Gastroenterol. 2016;111:147-8.
    PubMed    


  109. VALEUR J, Undseth R, Berstad A
    "Gahrungsdyspepsie" Revisited.
    Am J Gastroenterol. 2016;111:145-7.
    PubMed    


    October 2015
  110. CASSELL B, Gyawali CP, Kushnir VM, Gott BM, et al
    Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients.
    Am J Gastroenterol. 2015;110:1382-7.
    PubMed     Abstract available


    August 2015
  111. MENEES S, Powell C, Chey WD
    Response to Dai et al.
    Am J Gastroenterol. 2015;110:1243-4.
    PubMed    


  112. DAI C, Jiang M, Sun MJ
    The Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS.
    Am J Gastroenterol. 2015;110:1242-3.
    PubMed    


    July 2015
  113. PINTO-SANCHEZ MI, Ford AC, Avila CA, Verdu EF, et al
    Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.
    Am J Gastroenterol. 2015;110:1038-48.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: